June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
A hypothermia mimetic molecule (zr17-2) reduces ganglion cell death and prevents electroretinogram distortion following intraorbital optic nerve crush (IONC) in the rat
Author Affiliations & Notes
  • Ignacio M Larrayoz
    Biomarkers and Molecular Signaling, Fundacion Rioja Salud, Fundacion Rioja Salud, La Rioja, ES, other/health, Logroño, La Rioja, Spain
  • Daniela S Contartese
    Facultad de Medicina, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” (IBCN), CONICET - Universidad de Buenos Aires, Buenos Aires, Argentina
  • Manuel Rey-Funes
    Departamento de Biología Celular, Histología, Embriología y Genética, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” (IBCN), Universidad de Buenos Aires Facultad de Medicina, Buenos Aires, Argentina
  • Rafael Peláez
    Biomarkers and Molecular Signaling, Fundacion Rioja Salud, Fundacion Rioja Salud, La Rioja, ES, other/health, Logroño, La Rioja, Spain
  • Manuel Soliño
    Facultad de Medicina, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” (IBCN), CONICET - Universidad de Buenos Aires, Buenos Aires, Argentina
  • Juan Carlos Fernández
    Facultad de Medicina, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” (IBCN), CONICET - Universidad de Buenos Aires, Buenos Aires, Argentina
  • Nicolás Sebastián Ciranna
    Facultad de Medicina, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” (IBCN), CONICET - Universidad de Buenos Aires, Buenos Aires, Argentina
  • Anibal Sarotto
    Facultad de Medicina, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” (IBCN), CONICET - Universidad de Buenos Aires, Buenos Aires, Argentina
  • Veronica B Dorfman
    Universidad Maimonides Centro de Estudios Biomedicos Biotecnologicos Ambientales y Diagnostico, Buenos Aires, Argentina
  • Juan J López-Costa
    Facultad de Medicina, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” (IBCN), CONICET - Universidad de Buenos Aires, Buenos Aires, Argentina
    Departamento de Biología Celular, Histología, Embriología y Genética, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” (IBCN), Universidad de Buenos Aires Facultad de Medicina, Buenos Aires, Argentina
  • José M Zapico
    Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad CEU San Pablo, Madrid, Comunidad de Madrid, Spain
  • Ana Ramos
    Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad CEU San Pablo, Madrid, Comunidad de Madrid, Spain
  • Beatriz de Pascual-Teresa
    Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad CEU San Pablo, Madrid, Comunidad de Madrid, Spain
  • Cesar Fabián Loidl
    Facultad de Medicina, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” (IBCN), CONICET - Universidad de Buenos Aires, Buenos Aires, Argentina
    Departamento de Biología Celular, Histología, Embriología y Genética, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” (IBCN), Universidad de Buenos Aires Facultad de Medicina, Buenos Aires, Argentina
  • Alfredo Martínez
    Oncology Area, Fundacion Rioja Salud, Fundacion Rioja Salud, La Rioja, ES, other/health, Logroño, La Rioja, Spain
  • Footnotes
    Commercial Relationships   Ignacio Larrayoz, ES2680418A2 (P); Daniela Contartese, None; Manuel Rey-Funes, ES2680418A2 (P); Rafael Peláez, ES2680418A2 (P); Manuel Soliño, None; Juan Fernández, None; Nicolás Ciranna, None; Anibal Sarotto, None; Veronica Dorfman, None; Juan López-Costa, None; José Zapico, ES2680418A2 (P); Ana Ramos, ES2680418A2 (P); Beatriz de Pascual-Teresa, ES2680418A2 (P); Cesar Loidl, ES2680418A2 (P); Alfredo Martínez, ES2680418A2 (P)
  • Footnotes
    Support  This work was supported by Instituto Carlos III (CP15/00198 and CPII20/00029), Miguel Servet I y II Research Contract Programs, by Fondo Social Europeo (Periodo de Programación 2014 – 2020) «El FSE invierte en tu futuro»” y cofinanciado por el Fondo Europeo de Desarrollo Regional «Una manera de hacer Europa».
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 190. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ignacio M Larrayoz, Daniela S Contartese, Manuel Rey-Funes, Rafael Peláez, Manuel Soliño, Juan Carlos Fernández, Nicolás Sebastián Ciranna, Anibal Sarotto, Veronica B Dorfman, Juan J López-Costa, José M Zapico, Ana Ramos, Beatriz de Pascual-Teresa, Cesar Fabián Loidl, Alfredo Martínez; A hypothermia mimetic molecule (zr17-2) reduces ganglion cell death and prevents electroretinogram distortion following intraorbital optic nerve crush (IONC) in the rat. Invest. Ophthalmol. Vis. Sci. 2021;62(8):190.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Ocular and periocular traumatisms may result in loss of vision. Our previous work showed that hypothermia prevents retinal damage caused by traumatic neuropathy. We generated and characterized small molecules that elicit the beneficial effects of hypothermia at normal body temperature. Here we investigate whether one of these mimetic molecules, zr17-2, is able to preserve the function of retinas exposed to trauma.

Methods : Intraorbital optic nerve crush (IONC) or sham manipulation was applied to Sprague-Dawley rats. One hour after surgery, 5 ul of 330 nmols/L zr17-2 or PBS, as vehicle, were injected in the vitreum of treated animals. Electroretinograms were performed 30 days after surgery and a-, b-wave amplitude and oscillatory potentials (OP), were calculated. Animals for TUNEL analysis were sacrificed 6 days after surgery . Western blotting was performed for cold inducible RNA-binding protein (CIRP), the target of zr17-2.

Results : Previous studies showed that zr17-2 does not cross the blood-ocular barrier, thus preventing systemic treatment. Here we show that intravitreal injection of zr17-2 results in a very significant increase in CIRP protein expression in the eye, providing mechanistic support for its pharmacological use in ocular conditions. The amplitude of a- and b-waves, as well as the OP, was significantly reduced in IONC-affected retinas (p<0.05). These parameters were significantly corrected by injection of zr17-2 (p<0.05) (Fig. 1). IONC resulted in a very significant increase of TUNEL-positive cells in the ganglion cell layer (p<0.001) whereas injection of zr17-2 significantly reduced the number of apoptotic cells (p<0.001) (Fig. 2).

Conclusions : We have shown that intravitreal injection of the hypothermia mimetic, zr17-2, increases CIRP protein expression and, as a result, significantly reduces the morphological and electrophysiological consequences of ocular traumatism and may represent a new treatment for this cause of visual loss.
*DSC, *MR-F, *RP,contributed equally
#CFL, #AM and #IML contributed equally

This is a 2021 ARVO Annual Meeting abstract.

 

Figure 1. Amplitude of the b wave of the electroretinogram in the 4 experimental groups(n=10). *: p<0.05 vs sham; #:p<0.05 vs IONC vehicle.

Figure 1. Amplitude of the b wave of the electroretinogram in the 4 experimental groups(n=10). *: p<0.05 vs sham; #:p<0.05 vs IONC vehicle.

 

Figure 2. Quantification of TUNEL-positive cells in the ganglion cell layer of the 4 experimental groups (n=10). ***: p<0.001 vs sham; ###:p<0.001 vs IONC vehicle.

Figure 2. Quantification of TUNEL-positive cells in the ganglion cell layer of the 4 experimental groups (n=10). ***: p<0.001 vs sham; ###:p<0.001 vs IONC vehicle.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×